Evidence map›Paper›PMID 35102579›Full record

ArticleChild: care, health and development2022

Why young people stop taking their attention deficit hyperactivity disorder medication: A thematic analysis of interviews with young people.

Daniel Titheradge, Jo Godfrey, Helen Eke, Anna Price, Tamsin Ford, Astrid Janssens

Open access · hybridAbstract read
In one paragraph

Article in Child: care, health and development, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Daniel TitheradgeCollege of Medicine and Health, University of Exeter, Exeter, UK.ORCID 0000-0003-0540-2482
Jo GodfreyCollege of Medicine and Health, University of Exeter, Exeter, UK.ORCID 0000-0001-7074-9496
Helen EkeCollege of Medicine and Health, University of Exeter, Exeter, UK.ORCID 0000-0003-4781-6683
Anna PriceCollege of Medicine and Health, University of Exeter, Exeter, UK.ORCID 0000-0001-9147-1876
Tamsin FordCollege of Medicine and Health, University of Exeter, Exeter, UK.
Astrid JanssensCollege of Medicine and Health, University of Exeter, Exeter, UK.
University of Exeter · GBUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAttention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder that can persist into adulthood. Young people often stop taking ADHD medication during adolescence despite evidence that continuation would be beneficial. Increasingly, young people are restarting medication in early adulthood suggesting that cessation was premature. In this paper we explore the reasons given by young people for discontinuing ADHD medication.

methodsQualitative data from the Children and Adolescents with ADHD in Transition between Children's and Adult Services (CATCh-uS) project was analysed to look for reasons for stopping medication. Semi-structured interviews with three groups of young people were analysed using thematic and framework analysis; this included young people prior to transition (n = 21); young people that had successfully transitioned to adult services (n = 22); and young people who left children's services prior to transition but re-entered adult services later (n = 21).

resultsReasons given by young people for stopping ADHD medication included the following: the perceived balance between benefits and adverse effects of medication; perceptions of ADHD as a childhood or educational disorder; life circumstance of the young person and challenges young people faced in accessing services.

conclusionsA multidimensional approach is needed to address discontinuation of ADHD medication in order to improve the long-term prospects and quality of life for these young people. Possible approaches include access to non-pharmacological treatments and improved psychoeducation. As many reasons given by young people are not unique to ADHD, these findings are also of relevance to medication adherence in other chronic childhood conditions.

Indexed as

Attention Deficit Disorder with HyperactivityAdolescentAdultChildHumansMedication AdherenceQuality of Lifeadolescenceattention deficit hyperactivity disorder (ADHD)CATCh-uSmedicationtransition

Identifiers

PMID35102579
PMCPMC9545018
OpenAlexW4210605588

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.